Australia markets closed

Monopar Therapeutics Inc. (MNPR)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.6275-0.0295 (-4.49%)
At close: 04:00PM EDT
0.6201 -0.01 (-1.18%)
After hours: 05:31PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-8,402
-8,402
-10,516
-9,103
-6,305
Stock-based compensation
1,898
1,898
1,641
1,468
1,321
Change in working capital
-1,354
-1,354
1,646
317.769
443.809
Accounts payable
-1,334
-1,334
1,478
403.967
447.598
Other working capital
-7,858
-7,858
-7,229
-7,317
-4,662
Other non-cash items
-
-
-
-
-122.4
Net cash provided by operating activities
-7,858
-7,858
-7,229
-7,317
-4,662
Cash flows from investing activities
Purchases of investments
-7,882
-7,882
-4,919
0
-
Sales/maturities of investments
12,810
12,810
0
-
-
Net cash used for investing activities
4,928
4,928
-4,919
0
-
Cash flows from financing activities
Common stock issued
2,074
2,074
109.337
10,925
8,175
Other financing activities
-46.969
-46.969
-76.633
-63.253
-115.571
Net cash used provided by (used for) financing activities
2,027
2,027
32.873
10,880
8,182
Net change in cash
-920.114
-920.114
-12,118
3,567
3,523
Cash at beginning of period
8,186
8,186
20,304
16,737
13,214
Cash at end of period
7,266
7,266
8,186
20,304
16,737
Free cash flow
Operating cash flow
-7,858
-7,858
-7,229
-7,317
-4,662
Free cash flow
-7,858
-7,858
-7,229
-7,317
-4,662